Indications
Treatment of postoperative ocular inflammation following cataract extraction in adults.
Composition
- Active substance
- bromfenac sodium sesquihydrate
- International name (INN)
- bromfenac
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Yellox
- Active substance
- bromfenac sodium sesquihydrate
- ATC code
- S01BC11
- Group
- Sensory organs
- Therapeutic area
- Pain, Postoperative, Ophthalmologic Surgical Procedures
- Marketing authorisation holder
- Bausch + Lomb Ireland Limited
- Status
- Authorised